Back
ENDRA Life Sciences, Inc. 10K Form
Sell
41
NDRA
ENDRA Life Sciences, Inc.
Last Price:
$4.95
Seasonality Move:
5.28%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
| 2020-08-14 | 10Q | NDRA/ENDRA Life Sciences, Inc. Quarterly |
| 2020-05-14 | 10Q | NDRA/ENDRA Life Sciences, Inc. Quarterly |
| 2020-03-26 | 10K | NDRA/ENDRA Life Sciences, Inc. Annual |
| 2019-11-13 | 10Q | NDRA/ENDRA Life Sciences, Inc. Quarterly |
| 2019-08-08 | 10Q | NDRA/ENDRA Life Sciences, Inc. Quarterly |
| 2019-05-14 | 10Q | NDRA/ENDRA Life Sciences, Inc. Quarterly |
Receive NDRA News And Ratings
See the #1 stock for the next 7 days that we like better than NDRA
NDRA Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-1.2M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.22 |
| Price / Book: | 36.14 |
Profitability
| EPS (TTM): | -13.39230 |
|---|---|
| Net Income (TTM): | $-8M |
| Gross Margin: | $-206.2K |
| Return on Equity: | -318.69% |
| Return on Assets: | -192.72% |
ENDRA Life Sciences, Inc. Earnings Forecast
Key ENDRA Life Sciences, Inc. Financial Ratios
-
Per Share Earnings over the last 11 years have been positive in 6 years.
ENDRA Life Sciences, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Health Care Equipment & Supplies |
| Sector: | Health Care |
| Current Symbol: | NDRA |
| CUSIP: | 29273B |
| Website: | endrainc.com |
Debt
| Debt-to-Equity Ratio: | 3.06 |
|---|---|
| Current Ratio: | 1.31 |
| Quick Ratio: | 0.99 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
NDRA Technical Analysis vs Fundamental Analysis
Sell
41
ENDRA Life Sciences, Inc. (NDRA)
is a Sell
Is ENDRA Life Sciences, Inc. a Buy or a Sell?
-
ENDRA Life Sciences, Inc. stock is rated a SellThe current ENDRA Life Sciences, Inc. [NDRA] share price is $5.31. The Score for NDRA is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.